VUSE GO: Newest Product at Dortmund Tobacco Exhibition

Sep.18.2022
VUSE GO: Newest Product at Dortmund Tobacco Exhibition
2FIRSTS visited BAT's booth at the Dortmund tobacco expo and interviewed Daniel, who mentioned market changes and upcoming VUSE GO product launch.

On September 17th, 2FIRSTS frontline staff visited the BAT (British American Tobacco) booth at the Dortmund tobacco fair, where they interviewed Daniel, the person in charge.


2FIRSTS Interviews Daniel.


Daniel expressed that the past two years have been greatly impacted by the pandemic, with only participating in some online trade shows to barely maintain retail operations. Therefore, returning to the Dortmund tobacco expo this time is seen as a joyful event. Compared to the previous Dortmund tobacco expo, some changes in market structure were observed at this event. Daniel mentioned that "we can now see more small companies. Some of the big companies, who used to always exhibit as major suppliers, did not show up this time around.


During a discussion about products, a 2FIRSTS employee was drawn to a large "VUSE GO" poster displayed on a wall. They picked up the VUSE GO product from a display rack at the front desk and discovered that it was only the packaging. Daniel explained that it was just a demo and that the VUSE GO was going to be released soon. The poster below clearly stated "COMING SOON.


The VUSE GO poster displayed on the exhibition hall wall.


According to reports, VUSE GO is a disposable e-cigarette product launched as part of the VUSE series and is only available in a limited market. The official VUSE website states that VUSE GO comes in six different flavors, including watermelon, mango, blueberry, strawberry, mint, and creamy tobacco. Each device can be used for up to 500 puffs and comes in two variants with nicotine concentrations of 10mg and 20mg. In the UK, a single VUSE GO is priced at £5.99, while a package of six is available for £20.


According to reports, VUSE has surpassed JUUL as the top-selling e-cigarette in the United States this August. Even earlier, on July 27th, British American Tobacco announced during its half-year financial report that VUSE GO would be widely distributed throughout the European market in the second half of the year. The posters displayed on the wall at a tobacco exhibition in Dortmund seem to suggest that the full release of VUSE GO in Europe is not far away.


For more updates and news on the Dortmund tobacco exhibition in Germany, click on the link below.


1. This article is intended solely for communication and discussion within the industry and does not serve as a promotion or recommendation for any brands or products. 2. Smoking is detrimental to one's health. Minors are prohibited from reading this article.


This article is an original piece created by Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use belong to the company itself. Without authorization, no entity or individual may copy, reproduce, or use it in any other way that violates the company's copyright. Violators may be subject to legal action, which will be pursued by the company.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group releases 2025 results: tariffs and weaker demand weigh on performance, revenue about $1.4 billion
Scandinavian Tobacco Group (STG) reported its 2025 results: revenue was 9.036 billion Danish kroner (about $1.407 billion); EBITDA before special items was 1.791 billion Danish kroner (about $278 million); and free cash flow before acquisitions was 595 million Danish kroner (about $92.7 million). Multiple metrics declined year over year, and the company did not meet its Q3-updated guidance for revenue and free cash flow.
Mar.05 by 2FIRSTS.ai
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts Holds Second PMTA Compliance Training in Shenzhen, Highlighting U.S. Regulatory Framework and Corporate Compliance Capabilities
2Firsts held its second U.S. PMTA compliance training in Shenzhen, providing a systematic overview of the U.S. regulatory framework for e-cigarettes and corporate compliance strategies. Nearly 20 industry professionals from manufacturing, e-liquid and supply-chain companies attended. Participants who passed the exam received compliance certification. Registration for the third training session will open soon, alongside customized corporate training programs.
Mar.09
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
U.S. Adult Smoking Rate Falls to Historic Single-Digit Low of 9.9%, Study Shows Shift in Nicotine Use Patterns
A new study analyzing National Health Interview Survey data found that adult cigarette smoking in the United States declined to 9.9% in 2024, down from 10.8% in 2023. The findings, published in NEJM Evidence, represent a historic milestone in U.S. tobacco control efforts. Researchers noted that while cigarette smoking is decreasing, the prevalence of e-cigarette and cigar use remained largely unchanged, suggesting a shift in nicotine consumption rather than the elimination of tobacco use.
Market
Mar.20
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
Fifth Circuit Upholds FDA’s 2021 PMTA Rule, Citing Statutory Health-Study Requirements
A Fifth Circuit panel upheld the U.S. Food and Drug Administration’s 2021 final rule requiring companies seeking premarket authorization for new tobacco products to include information on health-risk investigations. In a published opinion, the court found FDA satisfied the Regulatory Flexibility Act’s procedural requirements and reasonably relied on the economic analysis from the 2016 “deeming rule” as a factual basis to certify limited impact on small businesses.
Feb.27 by 2FIRSTS.ai
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G to cancel 10.866 mln treasury shares, about 9.5% of shares outstanding
KT&G said it plans to cancel all treasury shares it holds, totaling 10,866,189 shares, representing about 9.5% of shares outstanding, in line with Korea’s third amendment to the Commercial Act requiring companies to cancel repurchased shares within one year. The company also disclosed progress on its shareholder-return plan and multiple agenda items for next month’s shareholders meeting.
Feb.26
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
FDA Says Flavored ENDS Must Show “Added Benefit” as Small Manufacturers Seek Clearer Switching Benchmarks
During the FDA PMTA roundtable session on “Studies of Adult Benefit,” officials said flavored ENDS must demonstrate “added benefit” over tobacco-flavored products under the APPH standard, including sustained complete switching evidence. Small manufacturers questioned switching benchmarks, study duration, and bridging expectations.
Feb.11